Digestive System Carcinoma Recruiting Phase 1 Trials for Temsirolimus (DB06287)

IndicationStatusPhase
DBCOND0079382 (Digestive System Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01552434Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTreatment